Article
Feasibility study of cancer genome alterations identified by next generation sequencing: ABC study.
Japanese journal of clinical oncology - 1 Jun 2018
Naito Yoichi, Takahashi Hideaki, Shitara Kohei, Okamoto Wataru, Bando Hideaki, Kuwata Takeshi, Kuboki Yasutoshi, Matsumoto Shingo, Miki Izumi, Yamanaka Takeharu, Watanabe Atsushi, Kojima Motohiro
Abstract excerpt
BACKGROUND: To confirm the feasibility and explore the clinical applicability of amplicon sequencing by next generation sequencing (NGS) of biopsy samples from patients with advanced solid tumors, we conducted a prospective study. METHODS: Patients with unresectable, advanced, or recurrent solid tumors were included. Key eligibility criteria were as follows: 20 years or older, any planned systemic therapy,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
